Dragomir Dardanov

Dr. Dragomir Dardanov

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

13 December 2023 in Medicina
Verified
Journal Article
Open access
PDF file
AYAneta Yacheva
Aneta Yacheva
DDDragomir Dardanov
Dragomir Dardanov
DZDora Zlatareva
Dora Zlatareva
Background and Objectives: Colorectal cancer is the third most common oncological disease worldwide. The standard treatment of locally advanced rectal tumors is neoadjuvant radiochemotherapy in combination with surgical resection. The choice of specific treatment algorithm is highly dependent on MRI findings. The aim of this study is to show the potential role of ADC measurements in rectal cancer and their usage in different clinical scenarios. Materials and Methods: A total of 135 patients had rectal MRI evaluation. Seventy-five (56%) had histologically proven rectal adenocarcinoma and sixty (44%) were evaluated as rectal disease-free. An ADC measurement in the most prominent region of interest was obtained for all patients. Eighteen patients (24% of the rectal cancer group) had a second MRI after neoadjuvant chemoradiotherapy with comparison of the ADC values at the same region of interest as previously measured. Results: Rectal cancer ADC values were found to be significantly lower than the ones in the control group (p < 0.001). A statistically significant correlation was found when ADC values in rectal tumors of different T stages were compared (p = 0.039)—those with higher T stage as in locally advanced disease showed lower ADC values. Patients with extramural vascular invasion showed significantly lower ADC values (p = 0.01). There was a significant increase in ADC values after treatment (p < 0.001), and a negative correlation was observed (r = −0.6572; p = 0.004)—tumors with low initial ADC values showed a higher increase in ADC. Conclusions: ADC measurements have a complementary role in the assessment of rectal cancer and have the potential to predict the response to chemoradiotherapy and improve the planning of proper treatment strategies.

6 October 2026 in Journal of Biomedical and Clinical Research
Verified
Journal Article
Open access
PDF file
DSDenislav Stanchev
Denislav Stanchev
DDDragomir Dardanov
Dragomir Dardanov
Aim: Low anterior resection syndrome (LARS) is a dysfunction of bowel evacuation following sphincter-preserving surgery (robotic, laparoscopic, or open) for rectal cancer. Patients commonly experience changes in bowel habits ranging from increased bowel frequency to faecal incontinence and evacuatory dysfunction. The aim of this study was to provide evidence-based recommendations for good clinical practice. Materials and methods: A literature search was conducted in PubMed and ResearchGate using the following keywords: low anterior resection syndrome, low anterior resection syndrome treatment, and low anterior resection syndrome scoring systems. Manual searches of references of the included studies were performed to identify other relevant publications. Only studies published in English were included. Results: In 2012 Emmertsen and Laurberg developed a questionnaire with a scoring system (the LARS score) that evaluates symptom severity and classifies patients into three groups: no LARS, minor LARS, and major LARS. A symptom-based therapeutic approach has been developed for the management of LARS. There is limited evidence that dietary modification improves symptoms. Medications such as loperamide and ramosetron have been shown to improve patients‘ quality of life. Pelvic floor rehabilitation is used to improve the function of the anal sphincter complex. Transanal irrigation has demonstrated significant improvement in symptoms. Sacral nerve modulation and posterior tibial nerve stimulation have shown promising results in patients with LARS who are resistant to conservative treatment. The creation of a colonic J-pouch has also been associated with a better quality of life compared with a straight coloanal or colorectal anastomosis. Conclusion: Many treatment modalities help relieve the symptoms of LARS; currently, however, no definitive cure exists. Further clinical research and studies are needed to develop effective treatment strategies and ultimately achieve a cure for LARS.

15 December 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
HCHaydar Celasin
Haydar Celasin
MTMurat Toruner
Murat Toruner
SASevda Aghayeva
Sevda Aghayeva
NBNuru Bayramov
Nuru Bayramov
AVArmen Vardanyan
Armen Vardanyan
IGİbRahim Ethem Geçim
İbRahim Ethem Geçim
Background: Since December 2019, the COVID-19 pandemic has created an increasing challenge in managing inflammatory bowel dis- ease patients both medically and surgically. Although several international and national medical/surgical associations published guide- lines in this area, there is still a huge difference between daily practices and these guidelines, especially depending on regional practices and governmental policies. Therefore, we aimed to investigate and define gastroenterologists’ and surgeons’ fear of COVID-19 and how they have managed inflammatory bowel disease patients during this pandemic in the Black Sea region. Methods: A 20-question survey was administered to 70 gastroenterology specialists and 80 general surgeons who are mainly focused on the management of inflammatory bowel disease in 5 countries in the Black Sea region. Results: The majority of respondents (81.3%) mentioned that they have concerns that their inflammatory bowel disease patients were at risk of contracting COVID-19. In addition, the majority of respondents (80.3%) believed that inflammatory bowel disease itself, inde- pendent of medications, might increase the risk of contracting COVID-19. The majority of gastroenterologists told that they did not stop inflammatory bowel disease medications due to the COVID-19 pandemic unless patients had COVID-19 disease. Surgeons overwhelm- ingly reached a consensus on how to test patients for COVID-19 perioperatively and came to a conclusion on which of the patients can- not wait to be operated. Both gastroenterologists and general surgeons, usually have similar perceptions. Conclusion: Despite the increasing number of definitive studies, it seems that there are still regional differences in the perception of COVID-19 and inflammatory bowel disease patient care during the pandemic. Cite this article as: Celasin H, Törüner M, Aghayeva S, et al. Perception of COVID-19 pandemic among IBD clinicians and IBD surgeons in Black Sea region: A cross-sectional questionnaire study. Turk J Gastroenterol. 2022;33(12):1004-1011.

1 September 2022 in ITEGAM-Journal of Engineering and Technology for Industrial Applications (ITEGAM-JETIA)
Verified
Journal Article
Open access
PDF file
EAElena Arabadzhieva
Elena Arabadzhieva
SBSasho Bonev
Sasho Bonev
DBDimitar Bulanov
Dimitar Bulanov
DDDragomir Dardanov
Dragomir Dardanov
GKGeorgi Korukov
Georgi Korukov
AYAtanas Yonkov
Atanas Yonkov
Postoperative liver failure (POLF) is one of the most serious complications in abdominal surgery, as its appearance is often associated with an unfavorable outcome.OBJECTIVE: To investigate the role of Indocyanine Green (ICG) and Indocyanine Green Retention rate (ICG-R15) for assessment of liver function in order to predict the risk of POLF.MATERIAL AND METHODS: In 06.2021 – 11.2022, a prospective study was conducted, including 20 patients admitted in University Hospital "Alexandrovska" for malignant liver neoplasms. Liver function was assessed by static biochemical parameters and intravenous ICG administration (0.5 mg/kg), aiming to measure the residual blood concentration at the 15th minute (ICG-R15). The results and the probable correlation with clinico-morphological features were processed statistically.RESULTS AND DISCUSSION: The study included 13 men (65%) and 7 women (35%) with primary (5) and metastatic (15) liver tumors. 13 minor (15%, major liver interventions were not undertaken (p=0.001). In the ICG-R15 <15% group, regardless of major resection performed, POLF was not observed. The lack of significant deviations in static liver indicators with marked differences in ICGR15 clearly shows the need to combine methods for a precise liver function assessment. POLF was rapidly controlled due to consideration of the resection volume in context of ICG-R15.CONCLUSION: The ICG-R15 is an easy, safe, and valuable tool for assessing liver function and identifying patients at risk of POLF. Additional studies are needed, as the present study is initial for Bulgaria.

20 September 2005 in Senologie - Zeitschrift für Mammadiagnostik und -therapie
Verified
Journal Article
Closed access
TDT. Deliyski
T. Deliyski
GBG. Baychev
G. Baychev
AIA. Ilieva
A. Ilieva
DDDragomir Dardanov
Dragomir Dardanov
DDD. Dimitrov
D. Dimitrov
Fur die klinische und wissenschaftliche Praxis würde es vom großen Interesse, wenn man eine Stelle in der Brust finden könnte, deren Lymphe unabhängig vom Sitz des Tumors zum Sentinellymphknoten abfliesst. Daher ist die retroareolare Region von besonderem Interesse, da wie es seit langer Zeit in der Literatur beschrieben wird, steht dieser Lymphbahnnetzwerk mit aller Lymphe der Brust in Zussamenhang. Ziel unserer Untersuchung ist den Lymphweg von der retroareolaren Region mit der Lymphbahn von der Tumorregion zu vergleichen und somit die Stelle der Sentinellumphknotenbiopsie durch die retroareolaren Farbstoffinjektion zu testen. Methode: Bei 43 Frauen mit Tumorsitz ausserhalb der Mamilla in c T1–2 N0 St. wurde retroareolar 2×0,7ml Patent Blue injektiert. Nach 6–8min wurden die SLNs mittels quer Inzision in der Axille gesucht. Ergebnisse: Es wurden bei 39 (90%) Frauen von 1 bis 3 SLNs gefunden. In 35 (80%) Fälle waren die Lymphknoten zweifarbig markiert. Nie wurden zwei verschiedene monofarbige (blaue oder grüne) Knoten gefunden. Zusammenfassung: Die Doppelfarbstoffmethode der retroareolaren und peritumoralen Farbstoffinjektion zeigt, dass beiden Regionen gleichen Lymhabfluss haben und dass die retroareolaren Injektion fur die Markierung der sentinellen Lymphknoten geeignet ist.